Lumos Diagnostics Holdings Limited (ASX:LDX)
0.2850
+0.0050 (1.79%)
Mar 18, 2026, 4:10 PM AEST
ASX:LDX Revenue
Lumos Diagnostics Holdings had revenue of $6.12M USD in the half year ending December 31, 2025, with 121.26% growth. This brings the company's revenue in the last twelve months to $12.21M, down -16.75% year-over-year. In the fiscal year ending June 30, 2025, Lumos Diagnostics Holdings had annual revenue of $12.40M with 11.40% growth.
Revenue (ttm)
$12.21M
Revenue Growth
-16.75%
P/S Ratio
12.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
223.36M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12.40M | 1.27M | 11.40% |
| Jun 30, 2024 | 11.13M | 596.00K | 5.66% |
| Jun 30, 2023 | 10.54M | -1.10M | -9.42% |
| Jun 30, 2022 | 11.63M | -7.22M | -38.32% |
| Jun 30, 2021 | 18.85M | 13.06M | 225.25% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PolyNovo | 139.49M |
| SomnoMed | 118.50M |
| Aroa Biosurgery | 79.26M |
| Compumedics | 58.49M |
| Nova Eye Medical | 33.05M |
| Micro-X | 16.90M |
| EMVision Medical Devices | 5.43M |
| Anteris Technologies Global | 2.87M |